175671-49-5

Basic information

• Product Name: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4S)-(9CI)
• Synonyms: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4S)-(9CI)
• CAS NO: 175671-49-5
• Molecular Formula: C6H11NO3
• Molecular Weight: 145.16
• Product Categories: CARBOXYLICACID
• Mol File: 175671-49-5.mol
• Article Data: 35

Chemical Properties

• Melting Point: 271-275℃
• Boiling Point: 404.1°C at 760 mmHg
• Flash Point: 198.2°C
• Appearance: /
• Density: 1.299
• Vapor Pressure: 3.27E-08mmHg at 25°C
• Refractive Index: 1.521
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4S)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4S)-(9CI)(175671-49-5)
• EPA Substance Registry System: 2-Piperidinecarboxylicacid,4-hydroxy-,(2R,4S)-(9CI)(175671-49-5)

Safety Data

• Hazardous Substances Data: 175671-49-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H19NO5/c1-11(2,3)17-10(16)12-5-4-7(13)6-8(12)9(14)15/h7-8,13H,4-6H2,1-3H3,(H,14,15)/t7-,8+/m1/s1

Upstream product

• 4382-31-4 (2S,4S)-4-hydroxy-2-piperidinecarboxylic acid 
• 106275-36-9 trans-4-hydroxy-N-tosyl-piperidine-2-carboxylic acid 
• 441044-14-0 phenylmethanaminium (2R,4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylate 
• 441044-11-7 (4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid 
• 653589-44-7 di(tert-butyl) (2S,4S)-4-hydroxy-1,2-piperidinedicarboxylate 
• 653589-35-6 di(tert-butyl) (2S,4R)-4-hydroxy-1,2-piperidinedicarboxylate 
• 402715-97-3 8-hydroxy-3,4-diphenylhexahydropyrido[2,1-c]-1,4-oxazin-1-one 
• 356073-50-2 (4S,8R,10S)-8-hydroxy-4-phenylhexahydropyrido[2,1-c][1,4]oxazin-1-one 
• 326477-58-1 (2S,4S)-(-)-4-Acetoxy-2-phenyl-1-trifluoroacetylpiperidine 
• 326477-50-3 (2R,4S)-(+)-4-Acetoxy-2-phenyl-1-trifluoroacetylpiperidine 
• 326477-51-4 (2R,4R)-(+)-4-Acetoxy-2-phenyl-1-trifluoroacetylpiperidine 
• 288620-86-0 (2S,4R)-4-Hydroxy-piperidine-1,2-dicarboxylic acid dibenzyl ester 
• 244633-64-5 5-(N-benzyloxycarbonyl)amino-2,4,5-trideoxy-L-threo-hexurono-6,3-lactone 
• 244793-56-4 Methanesulfonic acid 2-((2R,4R)-4-amino-5-oxo-tetrahydro-furan-2-yl)-ethyl ester 

Downstream Products

• 1844-40-2 (2S,4R)-4-hydroxypiperidine-2-carboxylic acid 
• 917099-02-6 (2S,4S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-hydroxy-2-piperidinecarboxylic acid 
• 441044-12-8 (2S,4S)-N-Boc-4-hydroxypiperidine-2-carboxylic acid 
• 441044-11-7 (4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid 
• 441044-14-0 phenylmethanaminium (2R,4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylate 
• 1212688-40-8 Boc-4-hydroxypipecolic acid 
• 441044-14-0 (2S,4S)-N-Boc-4-hydroxypiperidine-2-carboxylic acid benzylamine salt 
• 917099-02-6 (2S,4R)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-hydroxy-2-piperidinecarboxylic acid 
• 98593-76-1 (+)-1-Acetyl-4-hydroxy-D-pipecolinsaeurelacton 
• 98593-76-1 4-Hydroxypipecolinsaeurelactonacetat 

Relevant articles and documents

An Efficient Approach to the Family of 4-Substituted Pipecolic Acids. Syntheses of 4-Oxo-, cis-4-Hydroxy-, and trans-4-Hydroxy-L-pipecolic Acids from L-Aspartic Acid

Syntheses of 4-oxo-, cis-4-hydroxy-, and trans-4-hydroxy-L-pipecolic acids from L-aspartic acid using hexafluoroacetone as protecting reagent are described.Combination of a Stille cross-coupling reaction with subsequent Lewis acid catalyzed intramolecular Michael addition provides 4-oxo-L-pipecolic acid 5 or trans-6-methyl-4-oxo-L-pipecolic acid.Borohydride reduction of the protected 4-oxo-L-pipecolic acid derivative gives the corresponding cis-4-hydroxy-L-pipecolic acid 8.The trans isomer 10 is obtained in good yield via Mitsunobu inversion. - Key words: 4-Oxo-L-pipecolic acid, 4-hydroxy-L-pipecolic acids, L-aspartic acid, hexafluoroacetone, intramolecular Michael addition, Stille reaction

Damipipecolin and damituricin, novel bioactive bromopyrrole alkaloids from the Mediterranean sponge Axinella damicornis

Two new bromopyrrole alkaloids, damipipecolin (1) and damituricin (2), have been isolated from the Mediterranean sponge Axinella damicornis, and their structures established through spectroscopic methods. Compounds 1 and 2 extend the structural variety of

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Improved Total Synthesis of Tubulysins and Design, Synthesis, and Biological Evaluation of New Tubulysins with Highly Potent Cytotoxicities against Cancer Cells as Potential Payloads for Antibody-Drug Conjugates

Improved, streamlined total syntheses of natural tubulysins such as V (Tb45) and U (Tb46) and pretubulysin D (PTb-D43), and their application to the synthesis of designed tubulysin analogues (Tb44, PTb-D42, PTb-D47-PTb-D49, and Tb50-Tb120), are described.

AN ENANTIOSELECTIVE PROCESS FOR THE SYNTHESIS OF (2S,4R)-4-HYDROXYPIPECOLIC ACID

The present invention relates to an improved process for synthesis of 4-hydroxy pipecolic acid. The present invention relates to an improved enantioselective process for the synthesis of (2S,4R)-4-hydroxypipecolic acid via Co(III) (salen)-catalyzed two stereocentered Hydrolytic Kinetic Resolution (HKR) of racemic 1,3-azido epoxide with good yields and high optical purity without any protecting groups. 10 31